Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 12, 2016 3:37 PM ET

Biotechnology

Company Overview of Albireo AB

Company Overview

Albireo AB, a biotechnology company, focuses on the development of therapeutic drugs for gastrointestinal and liver diseases. Its pipeline programs include Elobixibat IBAT inhibitor for IBS-C and chronic constipation; A4250 IBAT inhibitor for cholestatic liver diseases; A3384 for bile acid mal-absorption; locally active PPAR agonists for IBD; IBAT inhibitor for type 2 diabetes and mellitus; and A3914 and A5425 NK antagonist for atopic dermatitis and psoriasis post-operative adhesions. Albireo AB was founded in 2008 and is based in Gothenburg, Sweden.

Arvid Wallgrens Backe 20

Gothenburg,  413 46

Sweden

Founded in 2008

Phone:

46 3 17 41 14 80

Fax:

46 31 82 02 23

Key Executives for Albireo AB

Acting Chief Financial Officer
Chief Operating Officer and Director
Vice President of Development
Vice President of Clinical & Regulatory Affairs
Compensation as of Fiscal Year 2015.

Albireo AB Key Developments

Albireo Limited Appoints Ron Cooper as President and Chief Executive Officer

Albireo Limited announced that Ron Cooper has joined the company as President and Chief Executive Officer. Mr. Cooper is a global biopharmaceutical leader with a track record of growing businesses, brands and organizations in the U.S. and Europe. He joins Albireo from Bristol-Myers Squibb (BMS), where he was President of Europe.

Albireo AB Presents at Boston Biotech Conferences 2015, Nov-12-2015 01:30 PM

Albireo AB Presents at Boston Biotech Conferences 2015, Nov-12-2015 01:30 PM. Venue: Apella, 450 East 29th Street, NY 10016, New York, United States. Speakers: Ron Cooper.

Similar Private Companies By Industry

Company Name Region
Plant Science Sweden AB Europe
Vascuring AB Europe
SenzaGen AB Europe
Vanadis Diagnostics, AB Europe
BIOEXTRAX AB Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Albireo AB, please visit www.albireopharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.